Cellectar Presents a New Phospholipid Drug Conjugate (PDC) at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference Oct 30, 2019
Cellectar Announces Poster at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference in Boston Oct 17, 2019
Cellectar Presents Poster at the Cancer Research UK-AACR Joint Conference on Engineering and Physical Sciences in Oncology Oct 15, 2019
Cellectar Announces Presentation at the Cancer Research UK-AACR Joint Conference on Engineering and Physical Sciences in Oncology Oct 8, 2019
Cellectar Presents Data from DLBCL Cohort of its Phase 2 CLOVER-1 Study at the European Society for Medical Oncology (ESMO) Congress Sep 30, 2019
Cellectar Receives Orphan Drug Designation from the European Commission for CLR 131 in Multiple Myeloma Sep 24, 2019
Cellectar Presents Data from Cohort 6 of its CLR 131 Phase 1 Study in Patients with Relapsed or Refractory Multiple Myeloma Sep 16, 2019
Cellectar Announces Oral Presentation at the European Society for Medical Oncology (ESMO) Congress 2019 Sep 10, 2019
Cellectar Announces Late-Breaker Poster Presentation at the 17th International Myeloma Workshop Sep 4, 2019